Rocket Pharmaceuticals, Inc. Stock Analysis & AI Score
Rocket Pharmaceuticals, Inc. (RCKT) has an ST Score of 54.1 (B-), driven by its Forecast (A+) and held back by its Momentum (D). Analysts rate it Buy with a $9.00 price target (+234.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Rocket Pharmaceuticals, Inc. (RCKT) has an ST Score of 54.1 (B-), driven by its Forecast (A+) and held back by its Momentum (D). Analysts rate it Buy with a $9.00 price target (+234.6% upside).
- Strongest
- ForecastA+
- Weakest
- MomentumD
All factor grades
- ForecastA+
- ValuationA-
- ProfitabilityA-
- Financial StrengthB-
- GrowthC
- MomentumD
- Piotroski1/9
Contact
RCKT stock: frequently asked questions
What is RCKT's ST Score?
Rocket Pharmaceuticals, Inc. (RCKT) has an ST Score of 54.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RCKT a buy, hold, or sell?
Analysts rate RCKT a Buy, with a price target of $9.00 (+234.6% vs the current price). Our ST Score grades it B- (54.1/100). The ST Score is a data-driven signal, not a recommendation.
What are RCKT's factor grades?
Valuation A-, Profitability A-, Financial Strength B-, Momentum D, Growth C, Forecast A+.
What is RCKT's valuation grade?
Rocket Pharmaceuticals, Inc. (RCKT) earns a valuation grade of A-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RCKT's growth grade?
Rocket Pharmaceuticals, Inc. (RCKT) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RCKT's profitability grade?
Rocket Pharmaceuticals, Inc. (RCKT) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RCKT's financial strength grade?
Rocket Pharmaceuticals, Inc. (RCKT) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for RCKT?
The average analyst price target for Rocket Pharmaceuticals, Inc. (RCKT) is $9.00 from 19 analysts, which is +234.6% versus the recent price of $2.69.
What is RCKT's Piotroski score?
Rocket Pharmaceuticals, Inc. (RCKT) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.